English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial
Shen, Yuanming; Kong, Beihua; Xia, Bairong; Wang, Fei; Yin, Rutie; Li, Qingshui; Yue, Ying; Kang, Shan; He, Liping; Wang, Ke; Meng, Yuanguang; Wang, Shixuan; Qu, Pengpeng; Huang, Xianghua; Guo, Ruixia; Yan, Ping; Pan, Mei; Lou, Ge; Cheng, Wenjun; Xie, Xing
华中科技大学; 吉林大学; 山东大学; 哈尔滨医科大学; 河北医科大学; 四川大学; 浙江大学; 郑州大学; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
2023-6-1
7
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试